Adherence to continuous screening for colorectal neoplasia

Medical Care

Volumn 31, Issue 6, 1993, Pages 508-519

  Myers, Ronald E ^a   Balshem, Andrew M ^a   Wolf, Thomas A ^a   Ross, Eric A ^a   Millner, Lois ^b  

^a FOX CHASE CANCER CENTER   (United States)

^b TEMPLE UNIVERSITY   (United States)

Author keywords

Adherence; Cancer; Colon; Repeat; Screening; Serial

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CLINICAL TRIAL; COLORECTAL TUMOR; DEMOGRAPHY; FEMALE; HEALTH MAINTENANCE ORGANIZATION; HUMAN; MALE; MASS SCREENING; METHODOLOGY; MULTIVARIATE ANALYSIS; OCCULT BLOOD; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; RISK; UNITED STATES; UTILIZATION REVIEW;

AGE FACTORS; AGED; COLORECTAL NEOPLASMS; DEMOGRAPHY; FEMALE; HEALTH MAINTENANCE ORGANIZATIONS; HUMAN; MALE; MASS SCREENING; MIDDLE AGE; MULTIVARIATE ANALYSIS; NEW JERSEY; OCCULT BLOOD; ODDS RATIO; PATIENT COMPLIANCE; PENNSYLVANIA; REGRESSION ANALYSIS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027618634     PISSN: 00257079     EISSN: 15371948     Source Type: Journal    
DOI: 10.1097/00005650-199306000-00004     Document Type: Article

References (37)

1. Schottenfeld D, Winawer SJ. Large intestine. In; Schottenfeld D, Fraumeni JF, Jr., eds. Cancer Epidemiology and Prevention. Philadelphia, PA: WB Saunders, 1982:703.
2. Ron E, Lubin F. Epidemiology of colorectal cancer and its relevance to screening. Frontiers in Gastrointestinal Research 1986; 10:1.
3. American Cancer Society. Cancer facts & figures. Atlanta, GA: American Cancer Society, 1991:10.
4. Hertz RE, Deddish MR, Day E. Value of periodic examinations in detecting cancer of the rectum and colon. Postgrad M 1960;27:290.
5. Winawer SJ. Detection and diagnosis of colorectal cancer. Cancer 1983;51:2519.
6. Moore JRL, LaMont JT. Colorectal cancer: Risk factors and screening strategies. Arch Intern Med 1984; 144:1819.
7. Fraumeni JF Jr, Mulvihill JJ. Who is at risk of colorectal cancer? In: Schottenfeld D, Fraumeni JF, Jr., eds. Cancer Epidemiology and Prevention, Springfield, IL: Thomas, 1975:404.
8. Winawer SJ, Schottenfeld D, Flehinger SJ. Colorectal Cancer screening. J Natl Cancer Inst 1991; 83:243.
9. Gilbertsen VA, McHugh R, Schuman L, Williams SE. Colon cancer control study: An interim report. In: Winawer SJ, Schottenfeld D, Sherlock P, eds.: Colorectal Cancer: Prevention, Epidemiology, and Screening. New YorkiRaven, 1980:261.
10. Hardcastle JD, Thomas W, Chamberlain J, Sheffield J, Balfour TW, Armitage NC. Randomized controlled trial of fecal occult blood screening for colorectal cancer: The results of the first 107,349 subjects. Lancet 1989; 1:1160.
11. Kronborg O, Fenger C, Olsen J, Bech K, Sander-gaard O. Repeated screening for colorectal cancer with fecal occult blood test: A prospective randomized study at Funen, Denmark. Scan J Gastroenterol 1989;24:599.
12. Kewenter J, Bjork S, Haglind E, Smith L, Svanvik J, Ahren C. Screening and rescreening for colorectal cancer: A controlled trial of fecal occult blood testing in 27,700 subjects. Cancer 1988;62:645.
13. Reiser JR. The emergence of the concept of screening for disease. Milbank Memorial Fund Quar-terly/Health and Society 1978;56:403.
14. Matte T, Fine L, Meinhardt T, Baker, E. Guidelines for medical screening in the workplace. Occup Med 1990;5:439.
15. Heimendinger J et al. Reducing the risk of cancer through worksite intervention. Occup Med 1990;5:707.
16. Mori H, Nakamura T, Nose Y. A method for early detection of abnormal trends in serial clinical examination results over time. Med Inf 1989;14:297.
17. Jansen JH. Participation in the first and second round of a mass-screening for colorectal cancer. Soc Sci Med 1984; 18:633.
18. Flehinger BJ, Herbert E, Winawer SJ, Miller DG. Screening for colorectal cancer with fecal occult blood test and sigmoidoscopy: Preliminary report of the colon project of Memorial Sloan-Kettering Cancer Center and PMI-Strang Clinic. In Chamberlain J, Miller A, eds.: Screening for Gastrointestinal Cancer. Toronto: Huber, 1988:9.
19. McGarrity T, Long P, Peiffer L. Results of a repeat television-advertised mass screening program for colorectal cancer using fecal occult blood tests. Am J Gastroenterol 1981; 85:266.
20. Meichenbaum D, Turk DC. Facilitation of Treatment Adherence: A Practitioner’s Handbook. New York: Plenum, 1987.
21. Hardcastle JB, Armitage NC, Chamberlain J, Amar SS, James PD, Balfour TW. Fecal occult blood screening for colorectal cancer in the general population. Cancer 1986;58:397.
22. Thompson RS, Michnich ME, Gray J, Fried-lander C, Gilson B. Maximizing compliance with he-moccult screening for colon cancer in clinical practice. Med Care 1986;24:904.
23. Myers R, Ross E, Wolf T, Balshem A, Jepson C, Millner L. Behavioral interventions to increase adherence in colorectal cancer screening. Med Care 1991; 29:1030.
24. Lerman C, Trock B, Rimer BK, Boyce A, Jepson C, Engstrom PF. Psychological and behavioral implications of abnormal mammograms. Ann Intern Med 1991; 114:657.
25. Snedecor GW, Cochran WG. Statistical Methods, 7th ed. Ames, Iowa: Iowa State University Press, 1980.
26. McNemar, O. Note on the sampling error of the difference between correlated proportions or percentages. Psychometrika 1947; 12:153.
27. Cox DR. Regression models and life tables. J Royal Statistical Society (B) 1972;34:187.
28. Haug M. Doctor patient relationships and the older patient. J Gerontol 1979; 34:852.
29. Easterling DV, Leventhal H. Contribution of concrete cognition to emotion: Neutral symptoms as elicitors of worry about cancer. J Appl Psychol 1989; 74:787.
30. Fleisher DE, Goldberg JE, Browning TH, Cooper JN, Friedman E, Goldner FH et al. Detection and surveillance of colorectal cancer. JAMA 1989; 261:580.
31. Ransohoff DF, Lang CA. Small adenomas detected during fecal occult blood test screening for colorectal cancer: The impact of serendipity. JAMA 1990; 264:76.
32. O’Brien MJ, Winawer SJ, Zauber AG, Gottlieb BS, Sternberg SS, Diaz B et al. The National Polyp Study: Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology 1990;98:371.
33. Knight KK, Fielding JE, Battista RN. Occult blood screening for colorectal cancer. JAMA 1989; 261:586.
34. Allison, JE, Tekawa, I, Ransom, L, Adrain, A. Combination fecal occult blood test (Hemoccult II, Sensa -Hemeselect): A promising alternative to Hemoccult II for detection of CR neoplasms in mass screening of average risk patients. Abstract accepted for presentation to the American Gastroenterological Asso-ciation/American Association for the Study of Liver Diseases meeting. San Francisco, CA, May 10-13, 1992.
35. Sidransky D, Tokino T, Hamilton SR, Kinzler KW, Levin B, Vogelstein B. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 1992;256:102.
36. Levin B. Screening sigmoidoscopy for colorectal cancer. N Engl J Med 1992;326:700.
37. Selby JV, Friedman GD. Sigmopidoscopy in the periodic health examination of asymptomatic adults. JAMA 1989; 261:595.